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Hepatitis A virus (HAV) infection is one of the main causes of 
acute viral hepatitis. As reported by the World Health Organi-
zation in 2019, about 1.4 million new cases of acute hepatitis 
A (AHA) occur globally every year. According to the Korea 
Centers for Disease Control and Prevention, HAV has recently 
re-emerged, and although most of the patients are in their 20s 
and 40s, many are also reported to be in their 60s and above.1 
In most patients, AHA is naturally recovered with lifelong pro-
tective immunity. However, about 10% of patients progress to 
atypical clinical courses such as prolonged hepatitis, relapsing 
hepatitis, cholestatic hepatitis, and autoimmune hepatitis 
(AIH).2,3 Several cases of AIH following AHA have been re-
ported, but the mechanism and pathophysiology still remain 
unclear.4-8
Recently, it has been shown that liver injury in patients with 
AHA is associated with quantitative and qualitative changes 
in the CD4+CD25+FoxP3+ regulatory T (Treg) cell population, 
including a decrease in their proportion9 and TNF produc-
tion.10 Here, we presented a patient who underwent liver trans-
plantation caused by autoimmune hepatic failure following 
AHA, and we performed an immunological analysis of Treg 
cells (IRB Number : 4-2015-0184, IRB Institution : Yonsei Uni-
versity Health System, Severance Hospital, Institutional Re-
view Board).
A 68-year-old female with no relevant medical history visit-
ed our emergency room complaining of constant fatigue, 
poor oral intake, and jaundice lasting 2 weeks. The laboratory 
data were as follows: alanine aminotransferase 1095 IU/L, as-
partate aminotransferase 740 IU/L, alkaline phosphatase 219 
IU/L, gamma-glutamyl transpeptidase 330 IU/L, and total bil-
irubin 14.5 mg/dL (direct fraction 11.1 mg/dL). Abdomino-
pelvic computed tomography (CT) revealed mild periportal 
edema and diffuse gallbladder wall edema, suggestive of AHA. 
Her immunoglobulin M (IgM) anti-hepatitis A virus (anti-HAV) 
antibody status was positive, but serological markers of viral 
hepatitis B and C infection were negative. In the diagnosis of 
AHA, with 3 days of conservative care, her symptoms and liver 
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function test were improved and she was discharged from 
hospital.
However, unlike with most AHA patients, during regular 
follow-up tests, her liver function had deteriorated repeatedly 
(Fig. 1A). Additional immunological tests revealed an anti-
nuclear antibody titer of 1:640, and the presence of perinucle-
ar anti-neutrophil cytoplasmic antibodies and anti-cardiolip-
in antibody. Although her IgM anti-HAV antibody status was 
positive, we suspected AIH according to the revised scoring 
system of the international AIH group, which was approved 
by the American Association for the Study of Liver Diseases 
(AALSD) in 2010 (score of 15).
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Fig. 1. (A) The results of subsequent liver function tests. The total bilirubin (blue line), aspartate aminotransferase (AST) (red line), and alanine aminotrans-
ferase (ALT) (yellow line) levels showed repeated deterioration during the course of the disease. Clinical courses, including admission, discharge, and liv-
er transplantation, are marked by black arrows. Three months after initial hospitalization, the patient was revealed to be positive for anti-nuclear antibody 
(ANA) (>1:640) and perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA). Her immunoglobulin M (IgM) anti-hepatitis A virus (anti-HAV) antibody 
status remained positive until after liver transplantation. (B-D) Flow cytometric analyses of Treg cells producing tumor necrosis factor-α (TNF-α), 
interferon-γ (IFN-γ), and interleukin-17A (IL-17A). Treg cells expressed higher levels of TNF-α (B), IFN-γ (C), and IL-17A (D) compared to Treg cells from a 
healthy donor. Healthy donor data are representative of those from six healthy donors. (E) TNF-α, IFN-γ, and IL-17A production by Treg cells of the patient 
gradually decreased to normal levels over the 6 months following liver transplantation (black arrow represents the time-point of liver transplantation).
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Six months after the first hospitalization, the patient experi-
enced recurrent abdominal distension, jaundice, and poor 
oral intake; as a result, she revisited our hospital. Laboratory 
tests revealed marked deterioration of liver function, and liver 
CT showed progression of liver cirrhosis affecting the collater-
al vessels, as well as extensive ascites. To determine the cause 
of hepatic function deterioration, we performed transjugular 
liver biopsy. In the results of liver biopsy, liver cirrhosis of stage 
4c was confirmed, and typical histology of AIH was found. We 
diagnosed liver failure attributable to acute deterioration of her 
hepatitis, and started 60 mg of prednisolone daily. Ten days lat-
er, she underwent liver transplantation. 
We performed intracellular cytokine staining and multi-col-
or flow cytometry to measure tumor necrosis factor-α (TNF-α) 
production by peripheral blood Treg cells, since the relative 
proportion of TNF-α-producing Treg cells is reported to be in-
creased (≤10% in average) and associated with liver injury in 
AHA patients.10 The proportion of TNF-α-producing Treg cells 
reached 18.6% on the day of liver transplantation (Fig. 1B). 
Treg cells also produced interferon-γ (IFN-γ) and interleukin-
17A (IL-17A) (Fig. 1C and D). However, cytokine production 
by CD8+ T cells and non-Treg CD4+ T cells was not elevated 
(data not shown). After liver transplantation, the clinical symp-
toms improved, CT scan revealed no abnormal findings, and 
the liver function normalized rapidly. TNF-α, IFN-γ, and IL-17A 
production by Treg cells decreased to normal levels (Fig. 1E). 
Since the 1990s, several cases of AIH developing after AHA 
have been reported. Individual genetic susceptibility to auto-
immune disease may play a role, but the pathophysiology re-
mains poorly understood. In our case, 68-year-old patient had 
suffered from AHA over the previous 6 months. Unlike typical 
AHA cases, she suffered from prolonged course of HAV infec-
tion with persisted IgM anti-HAV antibody. At the third wors-
ening of liver function, additional laboratory tests were per-
formed, and AIH was suspected (Fig. 1A). Although we did 
not examine autoimmune markers initially, considering that 
she had no past medical history of any autoimmune diseases, 
and initial radiologic tests and laboratory tests showed no sus-
pected autoimmune diseases, AIH seemed to be triggered by 
prolonged HAV infection. During the course of the disease, the 
patient’s IgM anti-HAV antibody remained constantly positive, 
and it only became negative after liver transplantation.
Recently, we showed that in AHA patients, Treg cells para-
doxically produce inflammatory cytokines, and the TNF-α-
producing Treg cells of AHA patients exhibit Th17-like proper-
ties and reduced suppressive function.11 Notably, the proportion 
of TNF-α-producing Treg cells in AHA patients was signifi-
cantly correlated with the extent of liver injury, indicating that 
such cells play a role in the induction of immune-mediated 
liver injury. Such changes usually normalize within 2–4 weeks 
after recovery from AHA. However, in our case, the proportion 
of TNF-α-producing Treg cells remained high. The prolonged 
AHA course was accompanied by TNF-α production by Treg 
cells; conversion of these cells into mediators of inflammation 
may have played a role in the observed autoimmune patho-
genesis. Further research is required to explore how changes 
in Treg cell populations trigger autoimmune complications 
after viral infection.
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